Press Release - Company Data

Depomed Announces Pricing of Upsized $300 Million Convertible Senior Notes Due 2021
Posted 2014-09-04 00:03NAI Editing
today announced that it has priced its registered offering of $300 million aggregate principal amount of Convertible Senior Notes due 2021 (the "Notes").

Depomed Announces Appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer
Posted 2014-07-16 00:05NAI Editing
today announced the appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer and Senior Vice President. Dr.

Mallinckrodt New Drug Application For MNK-155 Accepted For Review By FDA
Posted 2014-05-27 23:41NAI Editing
announced today that the U. S. Food and Drug Administration (FDA) has accepted for filing a New Drug Application (NDA) from Mallinckrodt (NYSE: MNK) for MNK-155.

Depomed Announces Settlements with Two Gralise® ANDA Filers
Posted 2014-04-13 23:29NAI Editing
today announced it has entered into settlement agreements with two of the three defendants involved in Depomed's ongoing patent infringement litigation against filers of Abbreviated New Drug Applicat

Depomed Earns $10 Million Milestone for FDA Approval of Mallinckrodt's XARTEMIS™ XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII)
Posted 2014-03-11 23:44NAI Editing
today announced that the U.S.

Depomed Announces Favorable Markman Ruling in GRALISE® Patent Litigation
Posted 2014-01-28 23:53NAI Editing
announced today a favorable "Markman" claim construction ruling by Judge Joel A.

Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
Posted 2013-07-08 06:06NAI Editing
today announced the appointment of Louis J. Lavigne, Jr. to the company's Board of Directors, and to the Board's Audit Committee. Mr.

Depomed Receives Notice of Paragraph IV Certification Against Patents for Zipsor®
Posted 2013-07-01 23:30NAI Editing
today announced that it has received a Paragraph IV certification notice from Banner Pharmacaps Inc.

FDA Issues Complete Response Letter on SEFELSA™ New Drug Application
Posted 2013-05-31 09:09NAI Editing
a specialty pharmaceutical company, announced today that the U.S.

Depomed Reports First Quarter 2013 Financial Results
Posted 2013-05-08 06:50NAI Editing
today reported financial results for the quarter ended March 31, 2013. First Quarter 2013 Update